Fig. 4From: The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, IranCost-effectiveness acceptability curve. The curve shows that BNP compared with standard clinical assessment was more cost-effective at the majority of willingness to pay thresholds. BNP has an 85% chance of being cost-effective versus standard clinical assessment with thresholds higher than USD20800Back to article page